reports
Finward Bancorp Announces Earnings for the Quarter Ended March 31, 202...
Finward Bancorp Announces Earnings for the Quarter Ended March 31, 2024 MUNSTER, Ind., April 24, 2024 (GLOBE NEWSWIRE) -- Finward Bancorp (Nasdaq: FNWD) (the “Bancorp”), the holding company for Peoples Bank (the “Bank”), today announced that net income available to common stockholders was $9.3 million, or $2.17 per diluted share, for the quarter ended March 31, 2024, as compared to $2.2 million, or $0.51 per diluted share, for the corresponding prior year period. Increases to our profitability results and performance ratio increases reported for quarter ended March 31, 2024 were primarily...
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study o...
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that clinical data from the dose escalation portion of the Phase 1b/2 study of FG-3246 in combination with enzalutamide in patients with metastatic castration resistant prostate cancer have been selected for a poster presentation...
Intra-Cellular Therapies Announces Closing of $575 Million Public Offe...
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has completed the sale of an additional 1,027,397 shares of its common stock at a public offering price of $73.00 per share on April 24, 2024, pursuant to the f...
Great Lakes Announces New $150,000,000 Second-Lien Financing Agreement
Great Lakes Announces New $150,000,000 Second-Lien Financing Agreement HOUSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the “Company”) (NASDAQ: GLDD), the largest provider of dredging services in the United States, announced that it has entered into a $150,000,000 5-year, senior secured second-lien credit agreement (“Second Lien Credit Agreement”) with Guggenheim Credit Funding, LLC, on behalf of one or more clients. The Company borrowed $100,000,000 under the Second Lien Credit Agreement on the Closing Date and has the option to draw an ...
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results ...
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, May 7, 2024 to report its first quarter 2024 financial results and provide a corporate update. To access the live conference call, participants may register . Wh...
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-36...
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event • Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 OncoSignature-negative) are being presented• A 50% confirmed overall response rate observed with ACR-368 in OncoSignature-positive gynecological (ovarian and endometrial) cancers• Initial clinical validation of AP3 patient selection platform, demonstrated ability to prospectively predict ACR-368 RECIST responders (p-value = 0.0038)•...
Iovance Biotherapeutics to Present Clinical and Translational Data at ...
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting Oral Presentation of Updated Results of IOV-COM-202 Cohort 1A of Lifileucel plus Pembrolizumab in Advanced Frontline Melanoma SAN CARLOS, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that clinical data for lifileucel in combination with pembroliz...
Capital Southwest Announces Fourth Quarter and Fiscal Year 2024 Earnin...
Capital Southwest Announces Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call Schedule Call Scheduled for 11:00 a.m. Eastern Time on Wednesday, May 15, 2024 DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest” or the “Company”; Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it will release its fourth quarter and fiscal year 2024 results on Tuesday, May 14, 2024, after t...
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma...
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical development and CMC costs over the next three years and an additional approximately $61 million in forecasted obligations through the patent life of rezafungin Cidara to further focus on advancing Cloudbreak development programs, including a planned IND filing for its lead oncology candidate, CBO421, as well a...
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at...
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting SAN MATEO, Calif. and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that it will present a study update of the oral CDK9 inhibitor KB-0742 in relapsed or refractory transcriptionally addicted advanced solid tumors from the ongoing Phase 1/2 trial, KB-0742-1001 (), at the American Society of Clinical Oncology (ASCO) Annual ...
- ABGSC Shipping & Transport Research
- Oliver Dunvold
- Petter Haugen
Mural Oncology Announces Upcoming Presentation at 2024 American Societ...
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced an upcoming poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting taking place May 31-June 4 in Chicago. The details are as follows: Recommended phase 2 dose...
The Honest Company to Report First Quarter Financial Results on May 8,...
The Honest Company to Report First Quarter Financial Results on May 8, 2024 LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating clean- and sustainably-designed products, today announced that it will report first quarter 2024 financial results after the market closes on Wednesday, May 8, 2024. The Company will host an investor conference call and webcast to review first quarter 2024 financial results at 1:30pm PT/4:30pm ET on the same day. The live webcast can be accessed at . For those interested in participatin...
InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Ind...
InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care Crenshaw Center Spotlights Impact of Participant-Centered, Coordinated Senior Care at No Cost to Eligible Seniors LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- (“InnovAge”) (Nasdaq: INNV), the healthcare industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrates the grand opening of its newest center in California. As part of this launch, InnovAge California PACE will host a l...
HMN Financial, Inc. Announces Dividend
HMN Financial, Inc. Announces Dividend ROCHESTER, Minn., April 24, 2024 (GLOBE NEWSWIRE) -- HMN Financial, Inc. (HMN or the Company) (Nasdaq:HMNF) today announced that its Board of Directors has declared a quarterly dividend of $0.10 per share of common stock, payable on June 7, 2024 to stockholders of record at the close of business on May 17, 2024. The declaration and amount of any future cash dividends remains subject to the sole discretion of the Board of Directors and will depend upon many factors, including the Company’s results of operations, financial condition, capital requiremen...
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Pr...
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting Late-breaking oral presentation on results from Phase 1/2 study of FLT201 in Gaucher disease Poster presentation to highlight Freeline’s GBA1 Parkinson’s disease research program LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- today announced the acceptance of multiple abstracts, including one for a late-breaking oral presentation on new clinical data from its Gaucher disease program, at the upcoming American Society of Gene and Cell Thera...
Splash Beverage Group Names Julius Ivancsits as Chief Financial Office...
Splash Beverage Group Names Julius Ivancsits as Chief Financial Officer FORT LAUDERDALE, FL, April 24, 2024 (GLOBE NEWSWIRE) -- via – (NYSE American: SBEV) ("Splash" or the "Company"), a portfolio company of leading beverage brands, today announced the appointment of Julius Ivancsits as Chief Financial Officer effective April 24th, 2024. Julius is a growth strategist with proven success scaling Public & PE-backed companies in both CPG and B2B organizations. “In addition, his prior experience in full deal cycle (diligence to integration) will play a critical role to Splash Beverage...
Verizon readies for 2024 wildfire season
Verizon readies for 2024 wildfire season Year-round preparation, hardened network infrastructure and mobile assets support disaster response DENVER, April 24, 2024 (GLOBE NEWSWIRE) -- As Wildfire Awareness Month approaches in May, Verizon is committed to maintaining the safety and connectivity of communities, businesses, and first responders nationwide. With wildfires increasing in both number and severity - like in Maui last year and more recently in West Texas - the need for year-long, round-the-clock preparedness has never been more critical. Verizon's teams are leading the charge, e...
Verizon readies for 2024 wildfire season
Verizon readies for 2024 wildfire season Year-round preparation, hardened network infrastructure and mobile assets support disaster response DENVER, April 24, 2024 (GLOBE NEWSWIRE) -- As Wildfire Awareness Month approaches in May, Verizon is committed to maintaining the safety and connectivity of communities, businesses, and first responders nationwide. With wildfires increasing in both number and severity - like in Maui last year and more recently in West Texas - the need for year-long, round-the-clock preparedness has never been more critical. Verizon's teams are leading the charge, e...
Verizon to offer Latin music fans the chance to win a VIP experience a...
Verizon to offer Latin music fans the chance to win a VIP experience at La Onda Verizon connects fans to the music they love at the inaugural edition of Festival La Onda by BottleRock® in Napa Valley, CA NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Starting today through May 13, Verizon is inviting Latin music fans to for a chance to win a trip to Festival La Onda by BottleRock®. Held June 1 & 2 at the Napa Valley Expo, the inaugural edition of this two-day music festival will bring together the hottest Latin musical acts across genres including regional Mexican, Latin pop, Spanish roc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.